Correction to: Efficacy and safety of trifluridine tipiracil in patients with metastatic colorectal cancer: a systematic review and metaanalysis

Huang, Fengxiang; Yang, Haiyan; Bao, Wenguang; Bin, Yehong; Zhou, Shengsheng; Wang, Man; Lv, Xiaoping

Huang, Fengxiang; Yang, Haiyan; Bao, Wenguang; Bin, Yehong; Zhou, Shengsheng; Wang, Man; Lv, Xiaoping.

Afiliação

Huang, Fengxiang; Guangxi Medical University. The First Affiliated Hospital. Department of Oncology. Nanning. China
Yang, Haiyan; Guangxi Medical University. The First Affiliated Hospital. Department of Oncology. Nanning. China
Bao, Wenguang; Guangxi Medical University. The First Affiliated Hospital. Department of Oncology. Nanning. China
Bin, Yehong; Guangxi Medical University. The First Affiliated Hospital. Department of Oncology. Nanning. China
Zhou, Shengsheng; Guangxi Medical University. The First Affiliated Hospital. Department of Oncology. Nanning. China
Wang, Man; Guangxi Medical University. The First Affiliated Hospital. Department of Oncology. Nanning. China
Lv, Xiaoping; Guangxi Medical University. The First Affiliated Hospital. Department of Oncology. Nanning. China

Clin. transl. oncol. (Print) ; 26(2): 554-554, feb. 2024.

Artigo em Inglês | IBECS | ID: ibc-230200

Biblioteca responsável: ES1.1

Localização: ES15.1 - BNCS

Assuntos

Humanos; Neoplasias Colorretais/tratamento farmacológico; Metástase Neoplásica/tratamento farmacológico; Antineoplásicos/administração & dosagem; Trifluridina/administração & dosagem; Resultado do Tratamento

Buscar no Google

Adicionar na Minha BVS

Imprimir

XML

Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Neoplasias Colorretais / Trifluridina / Metástase Neoplásica / Antineoplásicos Limite: Humanos Idioma: Inglês Revista: Clin. transl. oncol. (Print) Ano de publicação: 2024 Tipo de documento: Artigo Instituição/País de afiliação: Guangxi Medical University/China

Buscar no Google

Adicionar na Minha BVS

Imprimir

XML